ITGA6 and cancer: ITGA6 expression is linked to tumor development, aggressiveness, increased risk of recurrence, poor patient prognosis, shorter event-free survival, and overall survival time in cancer patients [8,22,31,40,50,57,61,70,103,124,125,126,127,128,129].